IGF1 and breast carcinoma: Insulin-like growth factor (IGF) binding protein 3 (IGFBP3) is a major carrier of IGF1 and IGF2 in circulation and IGFBP3 levels are reduced in breast cancer patients, giving rise to higher free IGF1 levels and poor prognosis (25,26).